Related Experiment Videos

[Treatment of septicopyemic forms of acute hematogenic osteomyelitis using dimexide and hyperbaric oxygenation]

Insights

Dimethyl sulfoxide (DMSO) and hyperbaric oxygen therapy (HBOT) effectively treated septicemic osteomyelitis in children. This combined approach improved patient outcomes, reduced swelling, and accelerated bone healing.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Regenerative Medicine

Context:

  • Septicopyemic forms of acute hematogenic osteomyelitis present significant treatment challenges.
  • Pediatric patients with severe bone infections require innovative therapeutic strategies.

Purpose:

  • To evaluate the efficacy of a combined therapeutic approach using Dimexide (dimethyl sulfoxide) and hyperbaric oxygen therapy (HBOT) for septicopyemic acute hematogenic osteomyelitis.
  • To assess the impact of this combined therapy on clinical and biochemical parameters in pediatric patients.

Summary:

  • The study involved 54 pediatric patients diagnosed with septicopyemic acute hematogenic osteomyelitis.
  • Patients received a curative complex incorporating Dimexide and HBOT.
  • Treatment outcomes were assessed based on general patient condition, tissue edema, osseous tissue repair, and blood indices.

Impact:

  • The integrated treatment regimen demonstrated significant effectiveness in managing severe osteomyelitis.
  • Observed improvements include enhanced general health, reduced tissue edema, stimulated bone repair processes, and normalized blood parameters.
  • This approach offers a promising strategy for improving recovery and reducing complications in pediatric osteomyelitis.

Related Concept Videos